Coty unveils debut scientific advisory board

By

Benjamin Fitzgerald

Published
September 25, 2024

Global beauty giant Coty announced on Tuesday the launch of its first-ever scientific advisory board, following its inaugural meeting on September 24.

The advisory board brings together globally renowned scientific experts from diverse technical disciplines, selected for their unique expertise and contribution to cutting-edge research, including Dr. Miriam Merad, MD, PhD – Director of Precision Immunology Institute; Dr. Emma Guttman, MD, PhD – Professor of Dermatology & Immunology; Dr. Patrick Bui, MD – Head of Plastic Surgery Department American Hospital; Pr. Selim Aractingi, MD, PhD – Team Leader, Cutaneous Biology Labs, Cochin Institute; Pr. Wei Liu, MD, PhD – Dermatologist'; Pr. Deng Xingwang – Professor of Life Science ; and Dr. Jaci Santana, MD – Dermatologist.

The board members will convene twice a year to inform breakthrough innovations within Coty’s R&D specialists, in a bid to strengthen Coty’s future in skincare. 

At the first meeting, held at Coty’s Skincare Research & Innovation Center of Excellence in Monaco, the leading scientists discussed the current themes in skin health and skin repair, providing insights and feedback that will shape Coty’s R&D initiatives and product innovation strategies across all its skincare brands, according to the France-based firm.

“This year marks our 120th anniversary as pioneers in the beauty industry, and I’m honored that such acclaimed scientific minds have agreed to come together to help define the future of Coty skincare as part of our scientific advisory board," said Sue Nabi, CEO of Coty.

"Each member has been carefully selected because they are at the forefront of their respective disciplines. Their ongoing insights will play a pivotal role as we continue to collaborate and drive skincare innovation forward for the benefit of all our consumers.”

In its most recent trading update, ​Coty missed fourth-quarter revenue expectations, impacted by its divestiture of Lacoste fragrance license and controlled orders from cautious retailers, which weighed on growth in prestige and mass-market perfumes.
​